Artículos Científicos

  • 2020
  • /
  • Pérez-Gómez, A., de Vries, H., Natera-Rey, G., Kokole, K., Bustamante, I., Braddick, F., Mejía-Trujillo, J., Solovei, A., Perez De Leon, A., Kaner, E., Matrai, S., Manthey, J., Mercken, L., López-Pelayo, H., Rowlands, G., Schmidt, C. & Rehm, J. (2020). Implementing primary healthcare-based measurement, advice and treatment for heavy drinking and comorbid depression at the municipal level in three Latin American countries: final protocol for a quasiexperimental study (SCALA study)

Pérez-Gómez, A., de Vries, H., Natera-Rey, G., Kokole, K., Bustamante, I., Braddick, F., Mejía-Trujillo, J., Solovei, A., Perez De Leon, A., Kaner, E., Matrai, S., Manthey, J., Mercken, L., López-Pelayo, H., Rowlands, G., Schmidt, C. & Rehm, J. (2020). Implementing primary healthcare-based measurement, advice and treatment for heavy drinking and comorbid depression at the municipal level in three Latin American countries: final protocol for a quasiexperimental study (SCALA study)

Introduction


This paper outlines the protocol for a quasiexperimental study1 to test the implementation of primary healthcare (PHC)-based measurement, advice and treatment for heavy drinking and comorbid depression at the municipal level in three Latin American countries, Colombia, Mexico and Peru (Scale-up of Prevention and Management of Alcohol Use Disorders and Comorbid Depression in Latin America (SCALA) study).

Heavy drinking is a cause of considerable disability, morbidity and mortality.2 Heavy drinking is a causal factor for some communicable diseases (including TB and HIV/AIDS), for many non-communicable diseases (NCDs, including cancers, cardiovascular diseases and gastrointestinal diseases) and for many mental and behavioural disorders, including depression, dementias and suicide.3 4

Link de descarga: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390229/